Clinical Trial Update: A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for rusfertide in patients with polycythemia vera; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Rusfertide (PTG-300)

Snippet

Sponsor: Protagonist Therapeutics, Inc. | Conditions: Polycythemia Vera | Phase 3 | Status: ACTIVE_NOT_RECRUITING